Citation Impact
50 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder
2024 Standout
Works of Paul N. Mudd being referenced
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
2022
Vibegron improves quality‐of‐life measures in patients with overactive bladder: Patient‐reported outcomes from the EMPOWUR study
2020
Author Peers
| Author | Urology | Rheumatology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Paul N. Mudd | 296 | 267 | 270 | 38 | 607 | |
| А.А. Гольева | 4 | 317 | ||||
| Marianna Földvári | 16 | 40 | 166 | 127 | 4.0k | |
| Anders Ljungberg | 9 | 57 | 42 | 11 | 334 | |
| Жу | 1 | 1 | 415 | 1.7k | ||
| G.B.Marini Bettolò | 5 | 44 | 783 |
All Works
Login with ORCID to disown or claim papers
Loading papers...